Large increase in ASD prevalence in Israel between 2017 and 2021 / Ilan DINSTEIN in Autism Research, 17-2 (February 2024)  

Public ISBD [article]  inAutism Research > 17-2 (February 2024) . - p.410-418 Titre : Large increase in ASD prevalence in Israel between 2017 and 2021 Type de document : texte imprimé Auteurs : Ilan DINSTEIN, Auteur ; Shirley SOLOMON, Auteur ; Michael ZATS, Auteur ; Ronit SHUSEL, Auteur ; Raphael LOTTNER, Auteur ; Bella Ben GERSHON, Auteur ; Gal MEIRI, Auteur ; Idan MENASHE, Auteur ; Dorit SHMUELI, Auteur Article en page(s) : p.410-418 Langues : Anglais (eng) Index. décimale : PER Périodiques Résumé : Abstract Accurate estimation of annual changes in autism spectrum disorders (ASD) prevalence is critical for planning the expansion of diagnostic, education, and intervention services at an adequate rate. Previous studies from Israel have reported that ASD prevalence among 8-year-old children has increased from estimates of 0.3% in 2008 to 0.65% in 2015 and 1.3% in 2018. Here, we analyzed data acquired from the National Insurance Institute of Israeli (NII), a governmental organization that approves and monitors all ASD children who receive welfare services in Israel, and Clalit Health Services (CHS), the largest Health Maintenance Organization in Israel that provides health services to ~52% of the population. Data from both sources included annual data files from 2017 to 2021 containing the number of ASD cases per year of birth for 1-17-year-old children. This allowed us to estimate annual ASD prevalence among 3.5 million children born between 2000 and 2020 in Israel. Both data sources revealed a nearly two-fold increase in ASD prevalence among 1-17-year-old children from 2017 to 2021. Estimated prevalence rates differed across age groups with 2-3-year-old (day-care) children increasing from 0.27% to 1.19% (>4 fold change), 4-6-year-old (pre-school) children increasing from 0.8% to 1.83%, and 8-year-old children increasing from 0.82% to 1.56% in NII data. These results demonstrate that autism prevalence continues to increase in Israel with a shift towards diagnosis at earlier ages. These findings highlight the challenge facing health and education service providers in meeting the needs of a rapidly growing autism population. En ligne : https://doi.org/10.1002/aur.3085 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=522 [article] Large increase in ASD prevalence in Israel between 2017 and 2021 [texte imprimé] / Ilan DINSTEIN, Auteur ; Shirley SOLOMON, Auteur ; Michael ZATS, Auteur ; Ronit SHUSEL, Auteur ; Raphael LOTTNER, Auteur ; Bella Ben GERSHON, Auteur ; Gal MEIRI, Auteur ; Idan MENASHE, Auteur ; Dorit SHMUELI, Auteur . - p.410-418. Langues : Anglais (eng) in Autism Research > 17-2 (February 2024) . - p.410-418 Index. décimale : PER Périodiques Résumé : Abstract Accurate estimation of annual changes in autism spectrum disorders (ASD) prevalence is critical for planning the expansion of diagnostic, education, and intervention services at an adequate rate. Previous studies from Israel have reported that ASD prevalence among 8-year-old children has increased from estimates of 0.3% in 2008 to 0.65% in 2015 and 1.3% in 2018. Here, we analyzed data acquired from the National Insurance Institute of Israeli (NII), a governmental organization that approves and monitors all ASD children who receive welfare services in Israel, and Clalit Health Services (CHS), the largest Health Maintenance Organization in Israel that provides health services to ~52% of the population. Data from both sources included annual data files from 2017 to 2021 containing the number of ASD cases per year of birth for 1-17-year-old children. This allowed us to estimate annual ASD prevalence among 3.5 million children born between 2000 and 2020 in Israel. Both data sources revealed a nearly two-fold increase in ASD prevalence among 1-17-year-old children from 2017 to 2021. Estimated prevalence rates differed across age groups with 2-3-year-old (day-care) children increasing from 0.27% to 1.19% (>4 fold change), 4-6-year-old (pre-school) children increasing from 0.8% to 1.83%, and 8-year-old children increasing from 0.82% to 1.56% in NII data. These results demonstrate that autism prevalence continues to increase in Israel with a shift towards diagnosis at earlier ages. These findings highlight the challenge facing health and education service providers in meeting the needs of a rapidly growing autism population. En ligne : https://doi.org/10.1002/aur.3085 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=522

Sleep disturbances are associated with greater healthcare utilization in children with autism spectrum disorder / Shirley SOLOMON in Journal of Neurodevelopmental Disorders, 16 (2024)  

Public ISBD [article]  inJournal of Neurodevelopmental Disorders > 16 (2024) Titre : Sleep disturbances are associated with greater healthcare utilization in children with autism spectrum disorder Type de document : texte imprimé Auteurs : Shirley SOLOMON, Auteur ; Leena ELBEDOUR, Auteur ; Gal MEIRI, Auteur ; Analya MICHAELOVSKI, Auteur ; Yair SADAKA, Auteur ; Michal ILAN, Auteur ; Michal FAROY, Auteur ; Ilan DINSTEIN, Auteur ; Idan MENASHE, Auteur Langues : Anglais (eng) Mots-clés : Humans  Autism Spectrum Disorder/complications/epidemiology/therapy  Male  Female  Sleep Wake Disorders/epidemiology/etiology/therapy  Child  Cross-Sectional Studies  Retrospective Studies  Patient Acceptance of Health Care/statistics & numerical data  Child, Preschool  Comorbidity  Adolescent  Hospitalization/statistics & numerical data  Autism  Autism spectrum disorder (ASD)  Co-occurring conditions  Healthcare utilization  Medication use  Melatonin  Sleep  Sleep disturbances Index. décimale : PER Périodiques Résumé : BACKGROUND: Sleep disturbances are frequently reported in children with autism spectrum disorder (ASD) and are associated with the severity of co-occurring symptoms. This study's aim was to examine the extent of healthcare utilization and clinical outcomes associated with sleep disturbances in children with ASD. STUDY DESIGN: A retrospective, cross-sectional study of 541 children with ASD from the Azrieli National Center for Autism and Neurodevelopment Research (ANCAN) whose parents completed the Children's Sleep Habits Questionnaire (CSHQ). Children with a total CSHQ score ≥ 48 were defined as having sleep disturbances. Sociodemographic characteristics, ASD diagnostic measures, chronic co-occurring conditions, medication usage, hospitalizations, visits to the emergency room (ER), and visits to specialists were compared in ASD children with and without sleep disturbances. Multivariate logistic regression models were then used to assess the independent association of sleep disturbances with clinical characteristics and healthcare utilization. RESULTS: Of the 541 children with ASD, 257 (47.5%) had sleep disturbances. Children with sleep disturbances exhibited higher rates of multiple (≥ 3) co-occurring conditions (19.1% vs. 12.7%; p = 0.0414) and prescribed medications (45.5% vs. 32.7%; p = 0.0031) than other children. Finally, ASD children with sleep disturbances were 1.72 and 2.71 times more likely to visit the ER and be hospitalized than their counterparts (aOR = 1.72; 99%CI = 1.01-2.95; and aOR = 2.71; 99%CI = 1.10-6.67, respectively). CONCLUSIONS: Our findings suggest that sleep disturbances are associated with greater healthcare utilization among children with ASD. Further studies could examine whether treating sleep disturbances in children with ASD yields additional clinical benefits beyond improvements in sleep. En ligne : https://dx.doi.org/10.1186/s11689-024-09550-z Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=575 [article] Sleep disturbances are associated with greater healthcare utilization in children with autism spectrum disorder [texte imprimé] / Shirley SOLOMON, Auteur ; Leena ELBEDOUR, Auteur ; Gal MEIRI, Auteur ; Analya MICHAELOVSKI, Auteur ; Yair SADAKA, Auteur ; Michal ILAN, Auteur ; Michal FAROY, Auteur ; Ilan DINSTEIN, Auteur ; Idan MENASHE, Auteur. Langues : Anglais (eng) in Journal of Neurodevelopmental Disorders > 16 (2024) Mots-clés : Humans  Autism Spectrum Disorder/complications/epidemiology/therapy  Male  Female  Sleep Wake Disorders/epidemiology/etiology/therapy  Child  Cross-Sectional Studies  Retrospective Studies  Patient Acceptance of Health Care/statistics & numerical data  Child, Preschool  Comorbidity  Adolescent  Hospitalization/statistics & numerical data  Autism  Autism spectrum disorder (ASD)  Co-occurring conditions  Healthcare utilization  Medication use  Melatonin  Sleep  Sleep disturbances Index. décimale : PER Périodiques Résumé : BACKGROUND: Sleep disturbances are frequently reported in children with autism spectrum disorder (ASD) and are associated with the severity of co-occurring symptoms. This study's aim was to examine the extent of healthcare utilization and clinical outcomes associated with sleep disturbances in children with ASD. STUDY DESIGN: A retrospective, cross-sectional study of 541 children with ASD from the Azrieli National Center for Autism and Neurodevelopment Research (ANCAN) whose parents completed the Children's Sleep Habits Questionnaire (CSHQ). Children with a total CSHQ score ≥ 48 were defined as having sleep disturbances. Sociodemographic characteristics, ASD diagnostic measures, chronic co-occurring conditions, medication usage, hospitalizations, visits to the emergency room (ER), and visits to specialists were compared in ASD children with and without sleep disturbances. Multivariate logistic regression models were then used to assess the independent association of sleep disturbances with clinical characteristics and healthcare utilization. RESULTS: Of the 541 children with ASD, 257 (47.5%) had sleep disturbances. Children with sleep disturbances exhibited higher rates of multiple (≥ 3) co-occurring conditions (19.1% vs. 12.7%; p = 0.0414) and prescribed medications (45.5% vs. 32.7%; p = 0.0031) than other children. Finally, ASD children with sleep disturbances were 1.72 and 2.71 times more likely to visit the ER and be hospitalized than their counterparts (aOR = 1.72; 99%CI = 1.01-2.95; and aOR = 2.71; 99%CI = 1.10-6.67, respectively). CONCLUSIONS: Our findings suggest that sleep disturbances are associated with greater healthcare utilization among children with ASD. Further studies could examine whether treating sleep disturbances in children with ASD yields additional clinical benefits beyond improvements in sleep. En ligne : https://dx.doi.org/10.1186/s11689-024-09550-z Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=575

---

1 (1 - 2 / 2) Par page : 25 50 100 200